Table 3.
Isolates |
Initial mean count1 | 0.3% bile | |
---|---|---|---|
24 h | Survival rate (%) | ||
TY5 | 8.8 ± 0.77 | 7.02 ± 0.04 | 79.77 |
TY12 | 8.58 ± 0.57 | 7.33 ± 0.76a | 85.4 |
TY14 | 6.42 ± 0.74 | 3.57 ± 0.18 | 55.6 |
AM3 | 7.44 ± 0.62 | 5.5 ± 0.28 | 73.92 |
AM15 | 6.69 ± 0.46 | 4.23 ± 0.82 | 63.2 |
AM20 | 8.64 ± 0.45 | 6 ± 0.14 | 71 |
PR3 | 8.93 ± 0.26 | 5.46 ± 0.81 | 61 |
PR14 | 6.58 ± 0.79 | 5.64 ± 0.07 | 85.7 |
PR45 | 8.44 ± 0.14 | 5.45 ± 0.60 | 64.6 |
ER5 | 7.95 ± 0.09 | 6.11 ± 0.03a | 76.8 |
MM39 | 7.78 ± 0.2 | 7.18 ± 0.2a | 92.28 |
MSS10 | 8.43 ± 0.65 | 6.79 ± 0.48a | 74.13 |
AB11 | 7.8 ± 0.30 | 6.6 ± 0.31a | 84.61 |
C2 | 8.11 ± 0.04 | 3.93 ± 0.80 | 48.45 |
AB1 | 8.7 ± 0.2 | 6.86 ± 0.17a | 80.3 |
AB8 | 7.52 ± 0.09 | 5.15 ± 0.02 | 68.48 |
W21 | 6.83 ± 0.08 | 3.54 ± 0.56 | 51.83 |
1Viable counts were transformed to log CFU/mL and expressed as mean ± SD from three experiments. aSignificant difference (P < 0.05) at log10 measurements after 12 h incubation at 0.3% compared to the initial count.